RxContinuity: Digital ADHD Prescription Passport for Established Patients
New doctors ignore prior diagnoses and long-term efficacy records, requiring costly and stressful rediagnoses before renewing Adderall prescriptions, especially during moves or provider changes.
Is the problem real?
ADHD patients with long-term Adderall history face repeated barriers to prescription renewal from new doctors, requiring excessive rediagnoses despite records and proven efficacy.
EVIDENCE
"This is why I gave up on the doctor and just diagnose and medicated myself."
commentThis is why I gave up on the doctor and just diagnose and medicated myself. It was rough in my 20s, but by my 30s I found out what works for me. Sucks to not have insurance cover anything but I just haven't had health insurance since I was 24 and idgaf. Saves me a bunch of $ and I'll find everything I need elsewhere. I've met literal gangsters that in my opinion are better people with better hearts than most of the Drs I had to deal with in my younger years.
Who feels this pain?
TARGET USERS
Adults with 5+ years documented Adderall use managing inattention, executive dysfunction and fatigue who frequently switch doctors or states and encounter rediagnosis demands.
Context
Current Workarounds
Where's the gap?
EXISTING SOLUTION GAPS
OPPORTUNITY & VALUE
Multiple explicit complaints about ignored records, rediagnosis demands, high costs, and resulting self-medication across long-term patients.
Focused exclusively on stimulant continuity documentation and provider matching for long-term patients rather than initial diagnosis or general telehealth.
A patient-owned digital passport app that securely compiles medical history, prescription records, symptom tracking, and provider handoff summaries to streamline continuity approvals with new ADHD-aware clinicians.
How does it make money?
MONETIZATION
Model
Patients already pay $300+ per new doctor visit and hundreds out-of-pocket; signals show strong motivation to avoid repeated denials and self-medication risks, making $19/mo a tiny fraction of avoided costs and stress.
How do you ship it?
MVP PLAN
“Carry your proven ADHD treatment history and skip redundant rediagnoses.”
A patient-owned digital passport app that securely compiles medical history, prescription records, symptom tracking, and provider handoff summaries to streamline continuity approvals with new ADHD-aware clinicians.
Core Features
Weekly Roadmap
- •Build encrypted document upload system
- •Create ADHD continuity summary template
- •Implement basic user authentication
- •Generate PDF export with verification stamps
- •Add secure share links with view controls
- •Seed directory with 50+ ADHD providers
- •End-to-end user testing with sample records
- •Basic analytics dashboard for users
- •Recruit beta users from ADHD forums
- •Integrate Stripe billing
- •Launch landing page and forum outreach
- •Monitor first 20 user conversions
Target ADHD Reddit communities (r/ADHD, r/adderall), patient forums, and Facebook groups with free trial offers and success story testimonials.
RISKS & ASSUMPTIONS
Top Risks
Handling controlled substance history requires strict compliance; any misstep risks shutdown or legal issues.
Physicians may still demand their own evaluations regardless of provided documentation.
Patients uploading incomplete or unverified records could reduce tool effectiveness.
Target users often face financial strain, potentially limiting paid subscription uptake.
Should you build it?
Run an Investment Memo to get a structured Go / No-Go verdict, competitor landscape, unit economics, and a 90-day validation roadmap for this opportunity.
Generate an investment memoWhat this score means
This opportunity scores well above the median for ideas surfaced by MonetScope, with a validation sub-score of 9/10 against 3 independently sourced evidence signals. A "strong" rating in this band typically means the pain signal is consistent and recurring across multiple discussions, but one of the three pillars (severity, willingness to pay, or competitor weakness) is somewhat softer than top-tier opportunities. Founders evaluating this should focus customer discovery on the softest pillar first — confirming the gap before committing engineering time to a build.
Why this matters for SaaS founders
It sits at the intersection of "ai-powered", "chronic-condition", "consultants", which makes it relevant to a specific subset of founders rather than a generic horizontal opportunity. SaaS opportunities at this stage tend to win on the strength of their initial wedge — a single workflow that the target user runs every week, where the existing solution is either spreadsheets, a clunky incumbent feature, or a manual process they hate. The build cost is moderate; the distribution cost is everything. The MonetScope pipeline surfaces this category alongside other saas signals, which is why it appears here rather than in a generic "trending ideas" feed.
Scores are derived from real forum discussions across Reddit, Hacker News and X, weighted by evidence volume and signal quality. How scoring works
Frequently asked questions
Is "RxContinuity: Digital ADHD Prescription Passport for Established Patients" a real validated startup idea or just an AI-generated suggestion?
MonetScope does not generate ideas from a language model's imagination. Every opportunity on this site is anchored to specific source posts and comments from real public discussions — typically on Reddit, Hacker News, or X — where actual users describe the pain in their own words. The AI's role is structuring, scoring, and grouping those signals into a navigable opportunity, not inventing the problem.
How recent is the underlying data for ai-powered?
MonetScope's spider pipeline runs continuously and surfaces opportunities as new evidence accumulates. The "Updated" date in the header reflects the most recent re-scoring of this specific opportunity. Most saas opportunities visible in the public catalog draw from discussions in the last 30-60 days; older signals are de-prioritized because user pain shifts faster than most founders assume.
What's the difference between "overall score" and "validation score"?
Overall score is a composite across six dimensions — pain, urgency, willingness to pay, market size, defensibility, and execution ease — designed to give a single number for triage. Validation score is narrower: it asks "how cleanly does the same signal repeat across independent sources?" An opportunity can score high on overall but lower on validation when one or two large discussions dominate the evidence; conversely, validation can be high on a smaller-overall idea where the signal is consistent but the addressable market is modest.